Загрузка...
Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer
SIMPLE SUMMARY: Incidence and death rates for endometrial cancer are steadily rising world-wide. Endometrial cancer patients at high risk for recurrence are treated with chemotherapy, which causes significant toxicity. Molecularly targeted drugs have been found to cause less toxicity than chemothera...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8150795/ https://ncbi.nlm.nih.gov/pubmed/34066052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102322 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|